Clinical Trial Update: Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating dentin hypersensitivity treatment using glass ionomer cements has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• Glass Ionomer Cement (glass ionomer cement)

Snippet

Sponsor: Federal University of Pelotas | Conditions: Dentin Hypersensitivity | Phase 2, Phase 3 | Status: COMPLETED